文献速递重症综合管理与镇静镇痛复苏、休克与脓毒症

固定化多粘菌素B滤器清除循环中性粒细胞胞外诱捕网组分:一项初步研究

Removal of Circulating Neutrophil Extracellular Trap Components With an Immobilized Polymyxin B Filter: A Preliminary Study.
PubMed 文献 · Shock · 2020-01-01
一句话结论离体和在体实验显示多粘菌素B滤器血液灌流可降低脓毒症患者血浆MPO-DNA和NE-DNA水平。

该初步研究评估了多粘菌素B(PMX)滤器血液灌流清除循环中性粒细胞胞外诱捕网(NETs)组分的效果。离体闭合环路实验中,脓毒症休克患者全血或健康志愿者经PMA刺激的中性粒细胞经PMX滤器灌流1和2小时后,MPO-DNA、NE-DNA和cf-DNA水平较无PMX滤器灌流显著降低。在体实验中,10例脓毒症患者经固定化PMX滤器直接血液灌流后,血浆MPO-DNA和NE-DNA水平显著降低。作者认为选择性清除循环NET组分可能对预防/治疗脓毒症患者NET相关的不适当炎症和血栓形成有效。

要点

  • 离体实验中,脓毒症休克患者全血经PMX滤器灌流1和2小时后,循环MPO-DNA、NE-DNA和cf-DNA水平较无PMX滤器灌流显著降低。
  • 健康志愿者经PMA刺激的中性粒细胞经PMX滤器灌流后,MPO-DNA、NE-DNA和cf-DNA水平同样显著降低。
  • 在体实验中,10例脓毒症患者经固定化PMX滤器直接血液灌流后,血浆MPO-DNA和NE-DNA水平显著降低。
  • PMX滤器原用于治疗革兰阴性菌感染,本研究显示其可清除循环NET组分。
  • 作者认为选择性清除循环NET组分可能对预防/治疗脓毒症患者NET相关的不适当炎症和血栓形成有效。

适用人群与场景

  • 脓毒症休克患者(离体实验使用其全血)
  • 脓毒症患者(在体实验,10例)
  • 健康志愿者(离体实验,其PMA刺激或未刺激的中性粒细胞)

处置流程与药物剂量

  • 离体实验:将脓毒症休克患者全血或健康志愿者(经PMA刺激或未刺激)全血通过含PMX滤器的闭合环路灌流,灌流1和2小时后检测NET组分。
  • 在体实验:对脓毒症患者行固定化PMX滤器直接血液灌流,灌流前后采集血样检测血浆NET组分。

研究设计与关键结果

  • 研究类型:初步研究,包含离体闭合环路血液灌流实验和在体实验。
  • 离体实验:PMA刺激2小时后,血浆MPO-DNA、NE-DNA和cf-DNA水平显著升高。
  • 离体实验:脓毒症休克患者全血或PMA刺激的健康志愿者中性粒细胞经PMX滤器灌流1和2小时后,循环MPO-DNA、NE-DNA和cf-DNA水平较无PMX滤器灌流显著降低。
  • 在体实验:10例脓毒症患者经固定化PMX滤器直接血液灌流后,血浆MPO-DNA和NE-DNA水平显著降低。

证据类型、等级与局限

  • 证据类型:初步研究(离体实验+在体实验)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为选择性清除循环NET组分可能对预防/治疗脓毒症患者NET相关的不适当炎症和血栓形成有效。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Components of neutrophil extracellular traps (NETs) are released into the circulation by neutrophils and contribute to microcirculatory disturbance in sepsis. Removing NET components (DNA, histones, and proteases) from the circulation could be a new strategy for counteracting NET-dependent tissue damage. We evaluated the effect of hemoperfusion with a polymyxin B (PMX) cartridge, which was originally developed for treating gram-negative infection, on circulating NET components in patients with septic shock, as well as the effect on phorbol myristate acetate (PMA)-stimulated neutrophils obtained from healthy volunteers. Ex vivo closed loop hemoperfusion was performed through PMX filters in a laboratory circuit. Whole blood from healthy volunteers (incubated with or without PMA) or from septic shock patients was perfused through the circuit. For in vivo experiment blood samples were collected before and immediately after hemoperfusion with PMX to measure the plasma levels of cell-free NETs. The level of cell-free NETs was assessed by measuring myeloperoxidase-associated DNA (MPO-DNA), neutrophil elastase-associated DNA (NE-DNA), and cell-free DNA (cf-DNA). Plasma levels of MPO-DNA, NE-DNA, and cf-DNA were significantly increased after 2 h of PMA stimulation. When the circuit was perfused with blood from septic shock patients or PMA-stimulated neutrophils from healthy volunteers, circulating levels of MPO-DNA, NE-DNA, and cf-DNA were significantly reduced after 1 and 2 h of perfusion with a PMX filter compared with perfusion without a PMX filter. In 10 patients with sepsis, direct hemoperfusion through filters with immobilized PMX significantly reduced plasma levels of MPO-DNA and NE-DNA. These ex vivo and in vivo findings demonstrated that hemoperfusion with PMX removes circulating NET components. Selective removal of circulating NET components from the blood could be effective for prevention/treatment of NET-related inappropriate inflammation and thrombogenesis in patients with sepsis.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Gocho T, Mori H, Islam MM, et al. Removal of Circulating Neutrophil Extracellular Trap Components With an Immobilized Polymyxin B Filter: A Preliminary Study. Shock. 2020. PMID: 31764624. doi:10.1097/SHK.0000000000001476

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。